Role of polymorphic variants as genetic modulators of infection in neonatal sepsis

Pediatric Research

Volumn 68, Issue 4, 2010, Pages 323-329

  Abu Maziad, Asmaa ^a,b   Schaa, Kendra ^a   Bell, Edward F ^a   Dagle, John M ^a   Cooper, Margaret ^c   Marazita, Mary L ^c   Murray, Jeffrey C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHOLIPASE A2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR;

ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CHORIOAMNIONITIS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GESTATIONAL AGE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; MEMBRANE RUPTURE; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GESTATIONAL AGE; GROUP II PHOSPHOLIPASES A2; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-10; IOWA; LOGISTIC MODELS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEPSIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 5;

EID: 77957255529     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181e6a068     Document Type: Article

References (42)

1. Stoll BJ, Hansen N 2003 Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol 27:293-301
2. Klein JO 2001 Bacterial sepsis and meningitis. In: Remington JS, Klein JO (eds) Infectious Diseases of the Fetus and Newborn Infant. 5th ed. W.B Saunders Co., Philadelphia, pp 943-998
3. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK 2002 Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291
4. Wolach B 1997 Neonatal sepsis: pathogenesis and supportive therapy. Semin Perinatol 21:28-38
5. Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM 1999 Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 104:1327-1333
6. Levy O 2005 Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 11:113-116
7. Levy O 2007 Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7:379-390
8. Wynn JL, Neu J, Moldawer LL, Levy O 2009 Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 29:79-88
9. Hotchkiss RS, Karl IE 2003 The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
10. Cohen J 2002 The immunopathogenesis of sepsis. Nature 420:885-891
11. Medzhitov R 2001 Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145
12. Janeway CA Jr, Medzhitov R 2002 Innate immune recognition. Annu Rev Immunol 20:197-216
13. Moore KW, De Waal Malefyt R, Coffman RL, O'Garra A 2001 Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765
14. Härtel C, Schultz C, Herting E, Göpel W 2007 Genetic association studies in VLBW infants exemplifying susceptibility to sepsis-recent findings and implications for future research. Acta Paediatr 96:158-165
15. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR; Neonatal Genetics Study Group 2006 Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117:1901-1906
16. Harding D 2007 Impact of common genetic variation on neonatal disease and outcome. Arch Dis Child Fetal Neonatal Ed 92:408-413
17. Papathanassoglou ED, Giannakopoulou MD, Bozas E 2006 Genomic variations and susceptibility to sepsis. AACN Adv Crit Care 17:394-422
18. Arcaroli J, Fessler MB, Abraham E 2005 Genetic polymorphisms and sepsis. Shock 24:300-312
19. Sutherland AM, Walley KR, Russell JA 2005 Polymorphisms in CD14, mannose-binding lectin, and toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 33:638-644
20. Baier RJ, Loggins J, Yanamandra K 2006 IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med 4:10
21. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA 2000 A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococ-cal infection. Infect Immun 68:6398-6401
22. Horvath S, Xu X, Laird NM 2001 The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9:301-306
23. Laird NM, Horvath S, Xu X 2000 Implementing a unified approach to family-based tests of association. Genet Epidemiol 19:S36-S42
24. Treszl A, Kocsis I, Szathmári M, Schuler A, Héninger E, Tulassay T, Vásárhelyi B 2003 Genetic variants of TNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 83:241-245
25. Chauhan M, McGuire W 2008 Interleukin-6 (-174C) polymorphism and the risk of sepsis in very-low-birth-weight infants: meta-analysis. Arch Dis Child Fetal Neonatal Ed 93:F427-F429
26. Jensen MD, Sheng W, Simonyi A, Johnson GS, Sun AY, Sun GY 2009 Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes. Neurochem Int 55:362-368
27. Elsbach P, Weiss J, Franson RC, Beckerdite-Quagliata S, Schneider A, Harris L 1979 Separation and purification of a potent bactericidal/permeability- increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. J Biol Chem 254:11000-11009
28. Weinrauch Y, Elsbach P, Madsen L, Foreman A, Weiss J 1996 The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 97:250-257
29. Huhtinen HT, Grönroos JO, Grönroos JM, Uksila J, Gelb MH, Nevalainen T, Laine VJ 2006 Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro. APMIS 114:127-130
30. Kumar H, Kawai T, Akira S 2009 Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388:621-625
31. Takeda K, Akira S 2005 Toll-like receptors in innate immunity. Int Immunol 17:1-14
32. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A 2001 The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature 410:1099-1103
33. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, Ozinsky A, Smith KD, Aderem A 2003 A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med 198:1563-1572
34. Del Vecchio A, Laforgia N, Capasso M, Iolascon A, Latini G 2004 The role of molecular genetics in the pathogenesis and diagnosis of neonatal sepsis. Clin Perinatol 31:53-67
35. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G, Fok TF 2003 Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 88:F209-F213
36. Romagnoli C, Frezza S, Cingolani A, De Luca A, Puopolo M, De Carolis MP, Vento G, Antinori A, Tortorolo G 2001 Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 160:345-350
37. Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel P, Dalhoff K 2003 Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 168:476-480
38. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hale E 2005 Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of Gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 24:635-639
39. Moore CE, Segal S, Berendt AR, Hill AV, Day NP 2004 Lack of association between toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus. Clin Diagn Lab Immunol 11:1194-1197
40. Schultz H, Weiss JP 2007 The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 384:12-23
41. Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, Repo H, Andersson S 2002 Extracellular release of bactericidal/permeability-increasing protein in newborn infants. Pediatr Res 51:670-674
42. Michalek J, Svetlikova P, Fedora M, Klimovic M, Klapacova L, Bartosova D, Elbl L, Hrstkova H, Hubacek JA 2007 Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med 33:2158-2164 (Pubitemid 350164567)